isol
fraction
thereof
inhibit
papain
retrospect
might
conclud
grob
detect
inhibitori
capac
plasma
protein
cystatin
c
lowand
highmolecularweight
kininogen
howev
major
multitud
present
identifi
cystein
proteas
inhibitor
isol
structur
function
character
b
comprehens
class
cystein
proteas
inhibitor
cystatin
superfamili
inhibitor
name
cystatin
origin
given
lowmolecularweight
inhibitor
papain
isol
chicken
egg
white
sinc
inhibitor
cvstein
proteas
inhibitor
middl
section
stat
cystatin
might
also
consid
allud
capac
cystatin
arrest
activ
cystein
proteas
sinc
stati
supin
stern
latin
verb
sisto
mean
arrest
agre
cystatin
use
denot
entir
superfamili
cystein
proteas
inhibitor
structur
function
relat
chicken
cystatin
cystatin
demonstr
higher
organ
also
larg
number
plant
lower
organ
includ
rice
seed
drosophila
candida
albican
amino
acid
sequenc
human
cystatin
c
fig
l
determin
sinc
display
signific
homolog
sequenc
protein
superfamili
known
evid
belong
new
protein
superfamili
retrospect
seen
amino
acid
sequenc
cystatin
c
first
sequenc
ofa
cystatin
determin
function
cystatin
c
inhibitor
cystein
proteas
identifi
year
later
sequenc
chicken
cystatin
determin
show
two
protein
sequenc
ident
studi
two
last
decad
identifi
human
cystein
proteas
inhibitor
display
strong
sequenc
homolog
cystatin
c
chicken
cystatin
consequ
belong
human
cystatin
superfamili
human
cystatin
famili
therefor
present
compris
identifi
protein
tabl
two
cystatin
b
form
famili
cystatin
mainli
exclus
intracellular
protein
cystatin
c
e
f
sa
sn
mainli
extracellular
andor
transcellular
protein
constitut
famili
cystatin
famili
cystatin
highand
lowmolecularweight
kininogen
contain
three
cystatin
domain
mainli
intravascular
protein
addit
inhibitor
cystein
proteas
precursor
molecul
product
vasoact
kinin
bradykinin
kallidin
highmolecularweight
kininogen
also
particip
contactphas
activ
endogen
blood
coagul
cascad
three
cystatin
domain
call
fig
amino
acid
sequenc
schemat
structur
human
cystatin
c
shade
area
mark
inhibitori
site
tbr
papainlik
cystein
proteas
overlap
inhibitori
site
mammalian
legumain
compris
inter
alia
asn
residu
arrow
indic
leu
residu
replac
gin
residu
cerebr
hemorrhag
produc
cystatin
c
variant
asterisk
mark
pro
residu
partli
hydroxyl
kininogen
inhibit
papainlik
cystein
proteas
also
calpain
figur
display
schemat
illustr
evolutionari
relationship
among
known
inhibitori
activ
cystatin
kininogen
cystatin
domain
human
cystatin
assum
major
biolog
role
inhibitor
one
target
proteas
human
andor
nonhuman
origin
identif
target
proteas
biomed
relev
howev
difficult
exampl
clearcut
identif
target
proteas
inhibitor
known
identif
usual
reli
experi
natur
man
two
exampl
identif
granulocyt
elastas
target
enzym
cqantitrypsin
reveal
pathophysiolog
ol
defici
emphysema
liver
cirrhosi
thrombin
target
enzym
lbr
antithrombin
reveal
pathophysiolog
antithrombin
defici
thromboembol
seriou
diseas
state
major
pathophysiolog
event
ascrib
lack
specif
inhibitori
capac
cystatin
far
describ
individu
complet
defici
highand
lowmolecularweight
kininogen
describ
seem
suffer
seriou
pathophysiolog
abnorm
mutat
gene
cystatin
b
c
produc
progress
myoclonu
epilepsi
li
hereditari
cerebr
hemorrhag
respect
present
knowledg
pathophysiolog
disord
allow
identif
target
proteas
cystatin
although
therefor
unequivoc
identif
target
proteas
human
cystatin
feasibl
yet
possibl
select
exclud
candid
target
proteas
differ
cystatin
base
upon
theoret
consider
b
well
upon
comparison
known
exampl
target
proteas
inter
alia
serin
proteas
inhibitor
mention
one
requir
must
fulfil
cystatin
render
biomed
signific
inhibitor
potenti
target
enzym
molar
concentr
cystatin
must
higher
activ
proteas
site
bodi
proteas
releas
second
requir
equilibrium
constant
dissoci
proteasecystatin
complex
must
low
secur
neglig
amount
free
proteolyt
activ
equilibrium
final
associ
rate
constant
format
proteasecystatin
complex
fic
schemat
diagram
evolutionari
relationship
among
known
inhibitori
activ
human
cystatin
kininogen
cystatin
domain
phylogenet
tree
construct
use
growtre
includ
gcg
softwar
packag
version
genet
comput
group
inc
madison
wi
phylogen
distanc
obtain
accord
method
kimura
reconstruct
tree
done
unweightedpair
group
method
use
arithmet
averag
must
high
free
proteas
activ
rapidli
quench
sinc
human
cystatin
display
uniqu
set
equilibrium
associ
rate
constant
test
limit
collect
cystein
proteas
cystatin
uniqu
inhibitori
spectrum
tabl
howev
inhibitori
spectra
usual
overlap
quit
probabl
cystatin
might
share
target
proteas
distribut
bodi
fluid
differ
cystatin
remark
differ
fig
exampl
cystatin
c
present
appreci
amount
investig
bodi
fluid
cystatin
sn
sa
virtual
confin
saliva
tear
semin
plasma
cystatin
present
saliva
tear
fluid
ai
bodi
compart
eg
spinal
fluid
cystatin
c
repres
total
molar
concentr
cystein
proteas
data
lii
inhibitor
compart
eg
blood
plasma
repres
percent
total
cystein
proteas
inhibitori
capac
moreov
total
cystein
proteaseinhibit
capac
vari
also
consider
among
differ
bodi
compart
exampl
total
papaininhibit
capac
blood
plasma
ixmol
cerebrospin
fluid
less
ixmol
sinc
bodi
fluid
display
uniqu
set
cystatin
also
clear
differ
bodi
fluid
display
uniqu
cystein
proteas
inhibitori
spectra
although
partial
overlap
like
inhibitori
spectra
individu
cystatin
tabl
show
differ
cystein
proteas
differ
catalyt
properti
control
separ
cystatin
variou
bodi
fluid
addit
inhibitor
papainlik
cystein
proteas
cystatin
c
recent
shown
effici
inhibitor
cystein
proteas
anoth
famili
cystein
proteas
call
peptidas
famili
c
human
legumain
typic
enzym
human
legumain
like
cathepsin
propos
involv
class
ii
mhc
present
antigen
also
shown
cystatin
c
inhibitori
site
mammalian
legumain
overlap
cystatin
c
inhibitori
site
papainlik
cystein
proteas
fig
cystatin
c
molecul
therefor
abl
simultan
inhibit
one
cystein
proteas
type
cystatin
c
also
suggest
possess
biolog
function
presum
unrel
proteaseinhibit
potenti
exampl
human
cystatin
c
describ
play
regulatori
role
inflammatori
process
imer
alia
downregul
phagocytosisassoci
respiratori
burst
reaction
display
polymorphonuclear
neutrophil
well
downregul
chemotact
respons
chicken
cystatin
thu
probabl
human
cystatin
c
also
shown
upregul
nitric
oxid
releas
periton
macrophag
howev
suggest
addit
function
cystatin
c
remain
confirm
protein
gener
design
function
name
cystatin
c
first
discov
function
cystein
proteas
inhibitor
thu
unidentifi
year
consequ
sever
trivial
name
use
protein
import
know
complet
retriev
data
cystatin
c
bibliograph
studi
follow
trivial
name
found
literatur
trace
post
globulin
gammacsf
postgamma
protein
cglobulin
high
alkalin
fraction
haf
sll
complet
amino
acid
sequenc
singl
polypeptid
chain
human
cystatin
c
determin
later
corrobor
identif
sequenc
correspond
cdna
fig
gene
threedimension
structur
cystatin
c
yet
determin
although
crystallograph
data
avail
presum
similar
describ
homolog
protein
chicken
cystatin
b
least
partial
confirm
nmr
studi
el
schemat
structur
human
cystatin
c
given
fig
studi
truncat
form
cystatin
c
cystatin
c
variant
produc
sitedirect
mutagenesi
b
hs
l
well
identif
sequenc
similar
cystatin
indic
inhibitori
center
cystatin
c
papainlik
cystein
proteas
compris
three
peptid
segment
peptidyl
deriv
structur
base
upon
aminotermin
segment
inhibitori
center
synthes
shown
effici
inhibitor
cystein
proteas
peptidyl
deriv
also
display
antibacteri
antivir
properti
b
tabl
display
physicochem
properti
cystatin
c
well
normal
concentr
bodi
fluid
investig
demonstr
diagnost
use
serum
level
cystatin
c
differ
plasma
level
cystatin
c
term
number
nucleotid
sequenc
start
first
nucleotid
proce
direct
amino
acid
number
begin
residu
l
matur
protein
put
hydrophob
signal
sequenc
thu
compris
residu
kozak
initi
consensu
polyadenyl
signal
underlin
serum
cystatin
c
therefor
follow
paragraph
unless
otherwis
indic
also
refer
plasma
level
cystatin
c
determin
structur
human
cystatin
c
gene
promot
demonstr
gene
housekeep
type
indic
stabl
product
rate
cystatin
c
nucleat
cell
type
presenc
hydrophob
leader
sequenc
precystatin
c
fig
strongli
indic
protein
normal
secret
inde
immunochem
northern
blot
studi
human
tissu
cell
line
shown
cystatin
c
andor
mrna
present
virtual
investig
cell
type
likewis
investig
product
cystatin
c
human
cell
line
cultur
display
nearli
cell
line
investig
secret
cystatin
c
b
abrahamson
person
commun
studi
serum
level
cystatin
c
larg
patient
cohort
fail
correl
serum
level
pathophysiolog
state
besid
affect
glomerular
filtrat
rate
also
compat
stabl
secret
cystatin
c
human
tissu
howev
report
describ
stimul
macrophag
vitro
downregul
secret
cystatin
c
w
l
inflammatori
condit
gener
associ
decreas
serum
level
cystatin
c
blood
plasma
protein
molecular
mass
kda
gener
almost
freeli
filter
normal
glomerular
membran
almost
complet
reabsorb
degrad
normal
proxim
tubular
cell
consequ
also
true
cystatin
c
molecular
mass
kda
probabl
ellipsoid
shape
axe
inde
studi
handl
human
cystatin
c
rat
shown
plasma
renal
clearanc
cystatin
c
gener
use
gfrmarker
cystatin
c
thu
practic
freeli
filter
glomeruli
least
filter
cystatin
c
found
degrad
tubular
cell
figur
show
rat
plasma
concentr
intact
human
c
rel
initi
concentr
intraven
inject
figur
display
plasma
disappear
cystatin
c
normal
nephrectom
rat
indic
renal
plasma
clearanc
cystatin
c
total
plasma
clearanc
renal
extraren
gfr
set
rat
variabl
lower
constrict
aorta
renal
arteri
renal
plasma
clearanc
cystatin
c
correl
strongli
fig
linear
regress
coeffici
r
intercept
statist
differ
observ
clearli
impli
insignific
peritubular
uptak
cystatin
c
immunohistochem
northern
blot
studi
human
kidney
also
strongli
indic
human
cystatin
c
normal
degrad
proxim
tubular
cell
passag
glomerular
membran
j
knowledg
human
tissu
produc
cystatin
c
lowmolecularmass
protein
remov
plasma
glomerular
filtrat
suggest
plasma
serum
level
might
potenti
good
marker
gfr
earli
investig
demonstr
serum
cystatin
c
inde
marker
gfr
least
good
serum
creatinin
popul
investig
studi
also
show
serum
cystatin
c
level
better
gfr
marker
serum
level
lowmolecularmass
protein
investig
retinolbind
protein
complement
factor
gi
howev
earli
studi
cystatin
c
concentr
determin
enzym
amplifi
singl
radial
immunodiffus
l
procedur
slow
requir
least
h
rel
high
coeffici
variat
decreas
use
obtain
serum
cystatin
c
valu
gfr
marker
clinic
routin
develop
year
later
autom
particleenhanc
immunoturbidimetr
method
rapid
well
precis
therefor
significantli
improv
possibl
use
serum
cystatin
c
gfr
marker
clinic
routin
work
introduct
sandwich
enzym
immunoassay
determin
serum
cystatin
c
sinc
autom
particleenhanc
immunoturbidimetr
procedur
determin
serum
cystatin
c
introduc
vast
major
studi
use
serum
cystatin
c
gfr
marker
reli
upon
commerci
avail
version
procedur
commerci
avail
autom
particleenhanc
immunonephelometr
method
also
recent
describ
serum
creatinin
ubiquit
use
indic
gfr
despit
knowledg
substanti
proport
patient
reduc
gfr
display
serum
creatinin
level
within
normal
rang
even
reduct
gfr
infrequ
associ
normal
concentr
serum
creatinin
ls
use
serum
creatinin
marker
gfr
limit
inter
alia
influenc
individu
muscl
mass
product
rate
creatinin
tubular
secret
reabsorpt
creatinin
dietari
intak
creatin
creatinin
analyt
difficulti
signific
limit
use
serum
creatinin
indic
gfr
made
interest
search
better
indic
gfr
sever
recent
studi
compar
use
serum
cystatin
c
creatinin
marker
gfr
determin
golden
standard
procedur
base
upon
determin
plasma
clearanc
inject
lowmolecularmass
substanc
crsiedta
iohexol
studi
indic
either
serum
cystatin
c
better
gfr
marker
serum
creatinin
particularli
individu
small
moder
decreas
gfr
socal
creatinineblind
gfr
rang
two
paramet
equal
valu
gfr
indic
figur
illustr
one
fl
correl
glomerular
filtrat
rate
top
reciproc
serum
cystatin
c
mgliter
bottom
reciproc
serum
creatinin
zmollit
male
femal
patient
lower
refer
limit
glomerular
fltration
rate
differ
diagnost
capac
serum
cystatin
c
serum
creatinin
identifi
patient
creatinineblind
area
glomerular
filtrat
rate
mlmin
x
obviou
investig
popul
patient
variou
renal
condit
diagnost
specif
fig
nonparametr
roc
plot
diagnost
accuraci
serum
cystatin
c
creatinm
distinguish
normal
reduc
glomerular
filtrat
rate
mlminx
respect
patient
variou
renal
condit
popul
one
display
fig
studi
indic
use
serum
cystatin
c
creatinineblind
gfr
rang
nearli
investig
emphas
serum
cystatin
c
contrast
serum
creatinin
uninfluenc
gender
muscl
mass
sever
studi
indic
virtual
refer
valu
might
use
serum
cystatin
c
male
femal
year
age
year
age
agerel
declin
gfr
becom
signific
serum
cystatin
c
also
describ
better
predictor
serum
creatinin
fast
total
homocystein
serum
level
probabl
closer
correl
gfr
solut
quantit
amino
acid
analysi
spectrophotometr
analysi
dilut
cystatin
cfree
human
serum
physiolog
concentr
base
upon
use
cystatin
c
calibr
commerci
avail
autom
particleenhanc
immunoturbidimetr
method
sever
studi
refer
valu
serum
cystatin
c
compris
popul
adult
children
publish
result
adult
gener
shown
sex
differ
age
group
wellknown
decreas
gfr
age
mirror
increas
cystatin
c
level
age
fig
howev
decreas
gfr
age
slow
year
age
suggest
suffici
practic
purpos
use
separ
refer
valu
age
group
year
age
tabl
result
children
fig
demonstr
cystatin
c
level
contrast
creatinin
level
constant
children
beyond
first
year
differ
sex
recommend
refer
valu
children
beyond
year
age
virtual
ident
recommend
adult
year
age
might
justifi
use
valu
age
group
tabl
emphas
howev
effici
intern
use
serum
cystatin
c
gfr
marker
requir
establish
gener
avail
intern
cystatin
c
calibr
rel
larg
variat
refer
valu
serum
cystatin
c
suggest
far
probabl
due
use
differ
often
illdescrib
cystatin
c
calibr
fic
serum
relat
age
popul
healthi
women
healthi
men
year
old
sex
differ
foun
influenc
age
glomerular
filtrat
rate
thu
serum
evid
sinc
plasma
protein
molecular
mass
kda
almost
freeli
filter
normal
glomerular
membran
serum
concentr
person
strongli
influenc
product
rate
also
often
least
extent
person
gfr
thu
product
rate
lowmolecularmass
protein
interest
evalu
biomed
process
diagnost
specif
ratio
serum
concentr
protein
cystatin
c
expect
higher
serum
concentr
specif
protein
exampl
influenc
age
gfr
thu
serum
level
fig
seen
ratio
serum
level
cystatin
c
fig
ratio
might
thu
specif
marker
cell
prolifer
isol
serum
level
first
autom
particleenhanc
immunoturbidimetr
method
introduc
claim
undisturb
hypertriglyceridemia
howev
widespread
clinic
use
sinc
demonstr
result
influenc
sampl
turbid
caus
inter
alia
chylomicronemia
might
produc
fals
low
high
valu
serum
cystatin
c
nilssonehl
r
submit
manuscript
grubb
unpublish
result
influenc
chylomicronemia
analyt
procedur
might
partli
explain
rel
larg
biolog
variat
report
serum
cystatin
c
well
outcom
studi
fail
show
advantag
serum
cystatin
c
serum
creatinin
gfr
marker
studi
biolog
variat
serum
fig
serum
c
ratio
relat
age
popul
healthi
women
healthi
men
year
old
serum
c
ratio
contrast
serum
level
separ
protein
influenc
agedepend
decreas
glomerutar
filtrat
rate
cystatin
c
use
nonturbid
sampl
indic
compar
serum
creatinin
nilssonehl
r
submit
manuscript
also
observ
rheumatoid
factor
interfer
present
use
particleenhanc
immunoturbidimetr
method
produc
erron
high
result
grubb
unpublish
result
also
emphas
although
precis
autom
particleenhanc
immunometr
method
higher
enzymeamplifi
singl
radial
immunodiffus
first
use
quantit
serum
cystatin
c
still
lower
method
determin
serum
creatinin
moreov
data
intraindividu
variat
serum
cystatin
c
strongli
indic
higher
precis
method
would
markedli
improv
clinic
use
serum
cystatin
c
determin
accord
criterion
cotlov
avail
evid
indic
serum
cystatin
c
better
marker
gfr
serum
creatinin
particularli
identif
initi
small
decreas
gfr
ie
socal
creatinineblind
gfr
rang
effici
use
knowledg
clinic
practic
requir
quantit
method
good
precis
undisturb
sampl
turbid
use
least
present
avail
particleenhanc
immunometr
method
seem
fulfil
first
criterion
accept
precis
nonturbid
fast
sampl
prefer
use
new
method
undisturb
turbid
develop
combin
use
serum
cystatin
c
creatinin
produc
best
possibl
inform
gfr
situat
accur
invas
expens
clearanc
determin
perform
biomed
econom
reason
serum
cystatin
c
creatinin
within
relev
refer
limit
risk
miss
decreas
gfr
minim
situat
gfr
determin
accur
invas
clearanc
method
either
serum
cystatin
c
creatinin
might
use
follow
chang
gfr
howev
long
precis
method
creatinin
determin
higher
method
cystatin
c
determin
present
valid
reason
use
serum
cystatin
c
purpos
particularli
sinc
creatinin
determin
gener
cheaper
cystatin
c
determin
observ
clear
possibl
renal
diseas
process
might
differ
affect
filtrat
cystatin
c
posit
charg
molecul
filtrat
creatinin
uncharg
molecul
inde
although
serum
cystatin
c
describ
better
gfr
marker
serum
creatinin
patient
renal
transplant
transplant
untranspl
patient
reduct
inulin
clearanc
report
display
differ
level
serum
cystatin
c
futur
studi
might
therefor
show
use
sever
gfr
marker
differ
physicochem
properti
might
optim
noninvas
monitor
kidney
function
sinc
cystatin
c
lowmolecularmass
protein
almost
freeli
filter
normal
glomerular
membran
nearli
complet
reabsorb
degrad
normal
proxim
tubular
cell
urin
level
cystatin
c
therefor
low
healthi
individu
mean
urin
cystatin
c
adult
healthi
popul
estim
raglit
mgmol
creatinin
rang
mgliter
mgmol
creatinin
proxim
tubular
dysfunct
result
impair
reabsorpt
lowmolecularmass
protein
increas
urinari
excret
cystatin
c
therefor
use
sensit
marker
diseas
process
affect
proxim
tubular
cell
c
howev
practic
use
urin
level
cystatin
c
marker
tubular
dysfunct
hamper
two
fact
first
upper
refer
limit
urin
concentr
cystatin
c
low
present
avail
rapid
cheap
immunochem
method
use
demonstr
small
increas
urinari
level
cystatin
c
signal
initi
often
revers
stage
proxim
tubular
dysfunct
second
cystatin
c
proteolyt
degrad
signific
proport
nativ
urin
sampl
g
although
two
difficulti
overcom
use
sensit
sophist
quantit
method
addit
preserv
urin
sampl
respect
state
affair
argu
practic
use
urin
cystatin
c
marker
proxim
tubular
dysfunct
urin
level
free
protein
hc
alia
eqmicroglobulin
seem
practic
marker
proxim
tubular
dysfunct
upper
refer
limit
high
raglit
mgmol
creatinin
sinc
protein
hc
stabl
nativ
urin
sampl
exclud
futur
studi
display
diagnost
potenti
urin
cystatin
c
urin
protein
hc
might
differ
diseas
state
sinc
cystatin
c
posit
charg
ph
rang
urin
protein
hc
neg
charg
cystatin
c
amyloid
deposit
demonstr
associ
two
type
brain
hemorrhag
one
type
dominantli
inherit
form
cerebr
hemorrhag
caus
mutat
cystatin
c
gene
display
amyloid
deposit
cystatin
c
variant
codeposit
amyloid
type
compris
cerebr
hemorrhag
condit
connect
cerebr
deposit
amyloid
display
codeposit
wildtyp
cystatin
c
amyloid
iceland
physician
arni
arnason
describ
sever
famili
suffer
high
incid
cerebr
hemorrhag
affect
young
adult
show
diseas
display
autosom
domin
inherit
fig
afflict
individu
gener
suffer
first
cerebr
bleed
year
age
subsequ
recurr
multifoc
cerebr
hemorrhag
possibl
identifi
carrier
trait
affect
famili
gudmundsson
et
al
show
diseas
associ
amyloid
deposit
mainli
locat
media
wall
cerebr
mediums
arteri
suggest
hereditari
cerebr
hemorrhag
amyloidosi
hchwa
suitabl
name
syndrom
g
ntermin
sequenc
main
compon
amyloid
fibril
determin
found
ident
sequenc
cystatin
c
start
residu
subsequ
immunohistochem
studi
corrobor
cystatin
c
major
compon
amyloid
deposit
show
also
vessel
tissu
outsid
central
nervou
system
contain
cystatin
c
amyloid
deposit
immunochem
quantit
level
cystatin
c
cerebrospin
fluid
demonstr
virtual
carrier
trait
diseas
independ
whether
suffer
first
cerebr
hemorrhag
could
identifi
low
cystatin
c
concentr
observ
allow
identif
healthi
carrier
diseas
trait
also
suggest
pivot
pathophysiolog
process
abnorm
metabol
cystatin
c
subsequ
studi
show
complet
sequenc
cystatin
c
polypeptid
chain
deposit
amyloid
one
individu
brain
hemorrhag
differ
one
posit
sequenc
previous
determin
cystatin
c
isol
swedish
patient
without
cerebr
hemorrhag
therefor
suggest
point
mutat
respons
amino
acid
substitut
glutamin
residu
replac
leucin
residu
posit
cystatin
c
polypeptid
chain
could
constitut
genet
background
diseas
although
also
might
repres
diseaseunrel
polymorph
potenti
diseasecaus
mutat
would
accord
sequenc
later
determin
fulllength
cdna
encod
cystatin
c
destroy
alu
icleavag
site
cystatin
c
gene
observ
allow
identif
restrict
fragment
length
polymorph
permit
identif
carrier
mutat
well
construct
simpl
rapid
polymeras
chain
reaction
pcr
base
procedur
purpos
individu
seven
afflict
famili
studi
observ
individu
suffer
earlyonset
cerebr
hemorrhag
carri
one
mutat
allel
healthi
rel
unrel
person
result
studi
therefor
permit
conclus
investig
mutat
caus
diseas
patient
heterozyg
two
design
diseas
origin
describ
arnason
present
use
viz
hereditari
cystatin
c
amyloid
angiopathi
hccaa
hereditari
cerebr
hemorrhag
amyloidosi
iceland
hchwai
first
mention
might
prefer
one
sinc
indic
amyloidform
protein
agre
recent
observ
amyloid
deposit
neither
confin
cerebr
vascultur
iceland
patient
also
appropri
design
condit
first
cerebr
hemorrhag
occur
diseas
consid
normotens
previous
healthi
individu
year
age
hit
sever
cerebr
hemorrhag
particularli
young
rel
previous
suffer
brain
hemorrhag
recurr
cerebr
hemorrhag
gener
occur
result
increas
motor
disabl
gradual
loss
mental
function
individu
diseas
progress
sever
year
carrier
mutat
allel
attain
normal
life
span
case
present
symptom
may
dementia
rather
brain
hemorrhag
diseas
uncommon
iceland
popul
case
describ
last
year
rare
describ
popul
hccaa
suspect
clinic
observ
andor
famili
histori
diagnosi
easili
verifi
demonstr
low
cerebrospin
fluid
level
cystatin
c
presenc
mutat
cystatin
c
allel
produc
leu
gln
cystatin
c
variant
firstment
procedur
requir
lumbar
punctur
secur
stabl
level
cystatin
c
sampl
addit
serin
proteas
inhibitor
eg
benzamidinium
chlorid
directli
sampl
drawn
grubb
unpublish
result
pcrbase
procedur
robust
requir
lumbar
punctur
use
prenat
diagnosi
therefor
present
prefer
diagnost
method
possibl
produc
diseasecaus
gln
cystatin
c
variant
escherichia
coli
express
system
parallel
studi
gln
cystatin
c
wildtyp
protein
reveal
although
effici
inhibitor
cystein
proteas
differ
consider
tendenc
dimer
form
aggreg
wildtyp
cystatin
c
monomer
function
activ
even
prolong
storag
elev
temperatur
gln
cystatin
c
start
dimer
lose
inhibitori
capac
immedi
isol
dimer
gln
cystatin
c
highli
temperaturedepend
rise
incub
temperatur
result
increas
dimer
rate
consider
concomit
rise
format
larger
aggreg
fig
pathophysiolog
process
gln
cystatin
c
due
tendenc
spontan
aggreg
partli
trap
intracellularli
secret
cell
effici
wildtyp
protein
continu
intracellular
accumul
gln
cystatin
c
would
combin
specif
physicochem
properti
lead
amyloid
format
cell
damag
death
recent
vitro
studi
inde
shown
intracellular
process
gln
cystatin
c
differ
wildtyp
cystatin
c
result
format
stabl
dimer
partial
retain
endoplasm
reticulum
b
also
assert
gln
cystatin
c
secret
cell
hccaa
patient
question
b
temperatur
depend
aggreg
gin
cystatin
c
might
clinic
relev
sinc
medic
intervent
abort
febril
episod
might
reduc
vivo
format
aggreg
carrier
diseas
trait
thu
possibl
delay
point
time
initi
brain
hemorrhag
cerebr
amyloid
angiopathi
wildtyp
variant
amyloid
protein
major
amyloid
constitu
condit
high
preval
elderli
also
commonli
found
patient
alzhemi
diseas
syndrom
condit
associ
cerebr
hemorrhag
may
account
brain
hemorrhag
case
elderli
immunohistochem
investig
amyloid
deposit
demonstr
consider
portion
display
cystatin
c
immunoreact
addit
amyloid
immunoreact
b
hi
quantit
estim
gener
indic
cystatin
c
minor
constitu
deposit
howev
effort
demonstr
presenc
cystatin
c
variant
eg
one
produc
hccaa
amyloid
deposit
far
unfruit
n
report
cerebrospin
fluid
level
cystatin
c
low
condit
observ
use
diagnost
purpos
still
uncertain
evid
pathophysiolog
signific
occurr
cystatin
c
minor
constitu
amyloid
deposit
condit
remain
determin
author
work
describ
discours
support
swedish
medic
research
council
project
osterlund
pfihlsson
g
j
kock
foundat
